Jonathan Violin is Director of Astria Therapeutics, Inc.. Currently has a direct ownership of 263,321 shares of ATXS, which is worth approximately $2.45 Million. The most recent transaction as insider was on Sep 20, 2021, when has been sold 263,321 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K
0% 3M change
0% 12M change
Total Value Held $2.45 Million

Jonathan Violin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2021
BUY
Other acquisition or disposition
-
263,321 Added 50.0%
263,321 Common Stock

Also insider at

VRDN
Viridian Therapeutics, Inc.\DE Healthcare
MGTA
Magenta Therapeutics, Inc. Healthcare
JV

Jonathan Violin

Director
Boulder, CO

Track Institutional and Insider Activities on ATXS

Follow Astria Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXS shares.

Notify only if

Insider Trading

Get notified when an Astria Therapeutics, Inc. insider buys or sells ATXS shares.

Notify only if

News

Receive news related to Astria Therapeutics, Inc.

Track Activities on ATXS